On 4/26/24, PTC Therapeutics Inc (NASDAQ: PTCT) stock enjoyed a major increase of 12.1%, closing at $28.57. Moreover, trading volume in this advance was unusually high at 176% of normal. The stock has been weak relative to the market over the last nine months but has risen 15.7% during the last week.
Current PriceTarget Research Rating
PTCT’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
PTC Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment